Allstate Corp Buys New Position in The Cooper Companies, Inc. $COO

Allstate Corp purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 7,668 shares of the medical device company’s stock, valued at approximately $526,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Buckhead Capital Management LLC raised its holdings in Cooper Companies by 14.3% in the 3rd quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock valued at $4,040,000 after acquiring an additional 7,368 shares during the last quarter. First American Bank purchased a new stake in shares of Cooper Companies in the third quarter valued at $1,646,000. Amundi grew its position in shares of Cooper Companies by 35.5% in the second quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock valued at $97,225,000 after purchasing an additional 348,652 shares during the period. Thompson Investment Management Inc. acquired a new position in Cooper Companies in the third quarter valued at $3,728,000. Finally, Westwood Holdings Group Inc. lifted its position in Cooper Companies by 23.4% during the second quarter. Westwood Holdings Group Inc. now owns 311,745 shares of the medical device company’s stock worth $22,184,000 after buying an additional 59,190 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on COO shares. Morgan Stanley lifted their price target on shares of Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, December 8th. Citigroup reaffirmed a “neutral” rating and issued a $88.00 target price (up from $72.00) on shares of Cooper Companies in a research report on Monday, December 8th. The Goldman Sachs Group reissued a “sell” rating and set a $73.00 price target on shares of Cooper Companies in a research report on Friday, January 9th. Piper Sandler restated an “overweight” rating and set a $94.00 price target (up from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. Finally, Weiss Ratings raised Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. Eight analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $90.31.

Cooper Companies Stock Up 0.3%

NASDAQ COO opened at $82.80 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $100.24. The business has a 50 day moving average price of $80.05 and a two-hundred day moving average price of $73.97. The stock has a market cap of $16.23 billion, a PE ratio of 44.04, a P/E/G ratio of 2.36 and a beta of 1.03.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The business had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Insider Buying and Selling

In other Cooper Companies news, Director Maria Rivas purchased 1,000 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The shares were acquired at an average price of $82.13 per share, for a total transaction of $82,130.00. Following the completion of the purchase, the director owned 11,141 shares in the company, valued at $915,010.33. The trade was a 9.86% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Lawrence Erik Kurzius purchased 2,000 shares of Cooper Companies stock in a transaction that occurred on Wednesday, December 17th. The stock was acquired at an average cost of $82.50 per share, with a total value of $165,000.00. Following the acquisition, the director directly owned 7,777 shares of the company’s stock, valued at $641,602.50. The trade was a 34.62% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 16,014 shares of company stock worth $1,304,416 over the last quarter. Company insiders own 1.98% of the company’s stock.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.